 high blood cholesterol level drug cost-effect pharmacolog manag cost-effect analysi pharmacolog treatment high blood cholesterol level agent cholestyramin colestipol gemfibrozil lovastatin niacin probucol pharmacolog effect studi cost estim societ resourc consumpt annual cost therapi niacin lovastatin mg/d niacin effici agent low-dens lipoprotein cholesterol level averag cost year percent reduct low-dens lipoprotein cholesterol level lovastatin mg/d effici percent reduct cholestyramin effici high-dens lipoprotein cholesterol niacin effici percent increas high-dens lipoprotein cholesterol level gemfibrozil analys low-dens lipoprotein cholesterol high-dens lipoprotein cholesterol effect niacin lovastatin mg/d effici cardiovascular risk